COVID-19 is still top of mind to investors in Valneva and Novavax, two developers of vaccines designed to offer protection, judging from the significant swings in opposite directions shown by the companies’ stock prices . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post StockWatch: Valneva, Novavax Stocks Swing with COVID-19 Developments appeared first on GEN – Genetic Engineering and Biotechnology News.
